Viewing Study NCT05473195


Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2025-12-31 @ 8:57 AM
Study NCT ID: NCT05473195
Status: COMPLETED
Last Update Posted: 2025-08-21
First Post: 2022-07-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098
Sponsor: TASK Applied Science
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: TASK-010-BETO
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View